NovaBiotics at North American Cystic Fibrosis Conference (NACFC), Indianapolis

NovaBiotics will be at North American Cystic Fibrosis Conference (NACFC) which is taking place in Indianapolis, Indiana, between the 2nd and 4th November 2017. NovaBiotics will present two posters at the conference, full details of which can be found below, providing an update on Cysteamine’s antimicrobial mechanism of action and the activity of  a novel antifungal, NP339, against clinically challenging and emerging fungal pathogens associated with CF.

#290 Mechanisms of Action of Cysteamine; A Late clinical stage candidate therapy for CF               

Thursday 2nd November               

11am-1.45pm

               

#400 A Novel peptide antifungal approach against respiratory fungal infections  

Thursday 2nd November

11am-1.45pm

 

NACFC is the leading conference in North America for clinicians, scientists, and health care providers involved in research and care for patients of cystic fibrosis. NACFC seeks to provide a collaborative forum to advance research for the treatment and cure of cystic fibrosis.